Poll: How comfortable are you with including biosimilars in your treatment plans?

Poll

Vote in our most recent poll!

How comfortable are you with including biosimilars in your treatment plans?

A. Very excited to begin embracing biosimilars
B. Feeling comfortable exploring biosimilar options, though cautiously
C. Still hesitant, I need to learn more about biosimilars
D. With the knowledge of biosimilars I have, I am not comfortable including this in my treatment plans

RELATED: Introduction to biosimilars for AMD

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Nora Lee Cothran, OD, FAAO, discussed the importance of optometrists addressing mental health with patients in their chair.
Matt Jones, OD; Matt Burns; and Joe Sugg, OD; detailed what optometrists can expect to change when HB 1353's regulations are enacted later this year.
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
© 2025 MJH Life Sciences

All rights reserved.